Terms: = Sarcomas AND MUC16, CA125, CA-125 AND Treatment
38 results:
1. Prognostic Factors for Uterine Sarcoma and Carcinosarcoma: Insights from a 10-Year Follow-Up Study.
Kotowicz B; Dańska-Bidzińska A; Fuksiewicz M; Nasierowska-Guttmejer A; Raczkiewicz D; Gujski M; Piątek S; Bidziński M
Med Sci Monit; 2023 Dec; 29():e941562. PubMed ID: 38058118
[TBL] [Abstract] [Full Text] [Related]
2. Monitoring treatment Response, Early Recurrence, and Survival in Uterine Serous Carcinoma and Carcinosarcoma Patients Using Personalized Circulating Tumor DNA Biomarkers.
Bellone S; McNamara B; Mutlu L; Demirkiran C; Hartwich TMP; Harold J; Yang-Hartwich Y; Siegel ER; Santin AD
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240216
[TBL] [Abstract] [Full Text] [Related]
3. Spatial transcriptomics reveal topological immune landscapes of Asian head and neck angiosarcoma.
Loh JW; Lee JY; Lim AH; Guan P; Lim BY; Kannan B; Lee ECY; Gu NX; Ko TK; Ng CC; Lim JCT; Yeong J; Lim JQ; Ong CK; Teh BT; Chan JY
Commun Biol; 2023 Apr; 6(1):461. PubMed ID: 37106027
[TBL] [Abstract] [Full Text] [Related]
4. Identification of methyltransferase modification genes associated with prognosis and immune features of pancreatic adenocarcinoma.
Wang W; Zhang D; Chang D; Li Y; Ren L
Mol Cell Probes; 2023 Feb; 67():101897. PubMed ID: 36740149
[TBL] [Abstract] [Full Text] [Related]
5. Primary leiomyosarcoma of ovary: A rare malignancy as an incidental finding.
Raychaudhuri S; Sidam D; Jain M; Chawla R; Pujani M; Wadhwa R
Indian J Pathol Microbiol; 2022; 65(4):938-941. PubMed ID: 36308213
[TBL] [Abstract] [Full Text] [Related]
6. The clinical characteristics and treatment of ovarian malignant mesoderm mixed tumor: a systematic review.
Wang X; Wang S; Yao S; Shi W; Ma K
J Ovarian Res; 2022 Sep; 15(1):104. PubMed ID: 36114551
[TBL] [Abstract] [Full Text] [Related]
7. Xanthogranulomatous inflammation caused by K. pneumonia and nocardiosis mimicking a uterine tumor and invading the ureter and colon: A case report and review of the literature.
Shen TA; Hsu YH; Ding DC
Taiwan J Obstet Gynecol; 2022 Sep; 61(5):889-895. PubMed ID: 36088063
[TBL] [Abstract] [Full Text] [Related]
8. [Clinical analysis of 23 cases with simultaneous double primary gynecological malignant tumors].
He Y; Wang Y; Ji C; Liu Y; Wu YM
Zhonghua Fu Chan Ke Za Zhi; 2022 May; 57(5):352-360. PubMed ID: 35658326
[No Abstract] [Full Text] [Related]
9. Primary low-grade extrauterine endometrial stromal sarcoma: analysis of 10 cases with a review of the literature.
Wu Y; Li N; Zhang R; Bai P
World J Surg Oncol; 2022 Jan; 20(1):17. PubMed ID: 35027071
[TBL] [Abstract] [Full Text] [Related]
10. Statistical analysis plan for the Dual mTorc Inhibition in advanCed/recurrent Epithelial ovarian, fallopian tube or primary peritoneal cancer (of clear cell, endometrioid and high-grade serous type, and carcinosarcoma) trial (DICE).
de la Rosa CN; Krell J; Day E; Clarke A; Reddi M; Webber L; Fiorentino F
Trials; 2022 Jan; 23(1):13. PubMed ID: 34986897
[TBL] [Abstract] [Full Text] [Related]
11. A case of retroperitoneal tumor displaying epithelial differentiation, prominent myxoid stroma and loss of INI1/SMARCB1.
Rekhi B; Thomas A
Pathologica; 2021 Dec; 113(6):456-462. PubMed ID: 34974552
[TBL] [Abstract] [Full Text] [Related]
12. [Surgical diagnosis and treatment of adult huge undifferentiated embryonal sarcoma of the liver].
Pu T; Chen JM; Guo Q; Yang LJ; Geng XP; Liu FB
Zhonghua Wai Ke Za Zhi; 2021 Oct; 59(10):848-853. PubMed ID: 34619911
[No Abstract] [Full Text] [Related]
13. [Mucinous Cystadenocarcinoma with a Sarcomatous Component Arising from the Sigmoid Mesocolon-A Case Report].
Rikiyama N; Ii T; Noguchi A; Kokumai T; Aoki Y; Sato H; Sato J; Kikuchi D; Miura I; Yamanami H
Gan To Kagaku Ryoho; 2021 Apr; 48(4):569-571. PubMed ID: 33976051
[TBL] [Abstract] [Full Text] [Related]
14. Molecular Biomarkers of Response to Eribulin in Patients with Leiomyosarcoma.
Wozniak A; Boeckx B; Modave E; Weaver A; Lambrechts D; Littlefield BA; Schöffski P
Clin Cancer Res; 2021 Jun; 27(11):3106-3115. PubMed ID: 33795257
[TBL] [Abstract] [Full Text] [Related]
15. Adjuvant treatment Modalities, Prognostic Factors, and Outcome of the Uterine Carcinosarcoma.
Kahramanoglu I; Demirkiran F; Turan H; Bese T; Cebi S; Ilvan S; Arvas M
J Obstet Gynaecol Can; 2021 Jan; 43(1):34-42. PubMed ID: 33041218
[TBL] [Abstract] [Full Text] [Related]
16. Unexpected tumor-to-tumor metastasis of synovial sarcoma within leiomyoma: A case report and literature review.
Sakai S; Morinaga Y; Koshiba A; Mori T; Kusuki I; Kitawaki J
J Obstet Gynaecol Res; 2020 Jul; 46(7):1216-1223. PubMed ID: 32452134
[TBL] [Abstract] [Full Text] [Related]
17. treatment of consistent BRAF/HRAS gene mutation and MYC amplification radiation-induced abdominal wall angiosarcoma with low-dose apatinib: a case report.
Guan J; Luo Z; Xiao Z; Xie Y; Lin L
BMC Cancer; 2019 Dec; 19(1):1188. PubMed ID: 31805975
[TBL] [Abstract] [Full Text] [Related]
18. Paraneoplastic cerebellar degeneration secondary to ovarian carcinosarcoma: a cerebellar conundrum.
Birch JD; Sen A; Rowland K; Viner T
BMJ Case Rep; 2017 Aug; 2017():. PubMed ID: 28790096
[TBL] [Abstract] [Full Text] [Related]
19. Primary Ewing's sarcoma/primitive neuroectodermal tumor of the ileum: case report of a 16-year-old Chinese female and literature review.
Li T; Zhang F; Cao Y; Ning S; Bi Y; Xue W; Ren L
Diagn Pathol; 2017 May; 12(1):37. PubMed ID: 28472972
[TBL] [Abstract] [Full Text] [Related]
20. Clinical factors of response in patients with advanced ovarian cancer participating in early phase clinical trials.
George A; Kristeleit R; Rafii S; Michie CO; Bowen R; Michalarea V; van Hagen T; Wong M; Rallis G; Molife LR; Lopez J; Banerji U; Banerjee SN; Gore ME; de Bono JS; Kaye SB; Yap TA
Eur J Cancer; 2017 May; 76():52-59. PubMed ID: 28273485
[TBL] [Abstract] [Full Text] [Related]
[Next]
